News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
181,551 Results
Type
Article (9586)
Company Profile (79)
Press Release (171886)
Multimedia
Podcasts (11)
Webinars (5)
Section
Business (50223)
Career Advice (332)
Deals (11950)
Drug Delivery (35)
Drug Development (21529)
Employer Resources (25)
FDA (4318)
Job Trends (4951)
News (87795)
Policy (7205)
Tag
2027 Biotech Bay Standard (1)
2027 Pharm Country Standard (1)
Academia (742)
Accelerated approval (11)
Adcomms (2)
Allergies (41)
Alliances (10336)
ALS (36)
Alzheimer's disease (426)
Antibody-drug conjugate (ADC) (78)
Approvals (4483)
Artificial intelligence (132)
Autoimmune disease (50)
Automation (10)
Bankruptcy (59)
Best Places to Work (3919)
BIOSECURE Act (4)
Biosimilars (46)
Biotechnology (56)
Bladder cancer (68)
Brain cancer (17)
Breast cancer (186)
Cancer (1449)
Cardiovascular disease (111)
Career advice (290)
Career pathing (9)
CAR-T (58)
CDC (12)
Cell therapy (193)
Cervical cancer (10)
Clinical research (19145)
Collaboration (371)
Company closure (1)
Compensation (89)
Complete response letters (12)
COVID-19 (908)
CRISPR (25)
C-suite (131)
Cystic fibrosis (49)
Data (2171)
Decentralized trials (2)
Denatured (1)
Depression (42)
Diabetes (161)
Diagnostics (1905)
Digital health (12)
Diversity (5)
Diversity, equity & inclusion (4)
Drug discovery (54)
Drug pricing (38)
Drug shortages (4)
Duchenne muscular dystrophy (70)
Earnings (30833)
Editorial (18)
Employer branding (4)
Employer resources (26)
Events (25743)
Executive appointments (141)
FDA (5328)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (1)
Frontotemporal dementia (3)
Funding (375)
Gene editing (45)
Generative AI (10)
Gene therapy (150)
GLP-1 (319)
Government (1130)
Grass and pollen (2)
Guidances (252)
Healthcare (5834)
HIV (22)
Huntington's disease (12)
IgA nephropathy (36)
Immunology and inflammation (64)
Immuno-oncology (17)
Indications (47)
Infectious disease (993)
Inflammatory bowel disease (56)
Inflation Reduction Act (1)
Influenza (29)
Intellectual property (40)
Interviews (45)
IPO (7242)
IRA (5)
Job creations (1156)
Job search strategy (246)
JPM (15)
Kidney cancer (10)
Labor market (37)
Layoffs (158)
Leadership (8)
Legal (1439)
Liver cancer (18)
Longevity (6)
Lung cancer (165)
Lymphoma (160)
Machine learning (10)
Management (11)
Manufacturing (211)
MASH (47)
Medical device (3968)
Medtech (3980)
Mergers & acquisitions (5151)
Metabolic disorders (391)
mRNA (31)
Multiple sclerosis (43)
NASH (6)
Neurodegenerative disease (85)
Neuropsychiatric disorders (25)
Neuroscience (743)
NextGen: Class of 2026 (1870)
Non-profit (1425)
Now hiring (15)
Obesity (179)
Opinion (51)
Ovarian cancer (61)
Pain (61)
Pancreatic cancer (47)
Parkinson's disease (64)
Partnered (12)
Patents (65)
Patient recruitment (117)
Peanut (20)
People (8482)
Pharmaceutical (18)
Pharmacy benefit managers (5)
Phase 1 (5370)
Phase 2 (8134)
Phase 3 (7275)
Pipeline (2338)
Policy (58)
Postmarket research (740)
Preclinical (1828)
Press Release (50)
Prostate cancer (92)
Psychedelics (9)
Radiopharmaceuticals (78)
Rare diseases (291)
Real estate (1745)
Recruiting (12)
Regulatory (5866)
Reports (13)
Research institute (706)
Resumes & cover letters (57)
Rett syndrome (10)
RNA editing (2)
RSV (24)
Schizophrenia (51)
Series A (71)
Series B (41)
Service/supplier (3)
Sickle cell disease (36)
Special edition (13)
Spinal muscular atrophy (71)
Sponsored (14)
Startups (768)
State (1)
Stomach cancer (2)
Supply chain (27)
Tariffs (20)
The Weekly (10)
Vaccines (268)
Venture capital (24)
Weight loss (110)
Women's health (21)
Worklife (3)
Date
Today (64)
Last 7 days (331)
Last 30 days (832)
Last 365 days (8947)
2026 (1372)
2025 (8948)
2024 (10095)
2023 (11606)
2022 (13929)
2021 (15496)
2020 (15225)
2019 (13911)
2018 (10514)
2017 (8471)
2016 (8055)
2015 (9490)
2014 (6475)
2013 (4882)
2012 (5423)
2011 (5628)
2010 (4753)
Location
Africa (199)
Alabama (15)
Alaska (1)
Arizona (80)
Arkansas (1)
Asia (10617)
Australia (1571)
California (3164)
Canada (920)
China (307)
Colorado (129)
Connecticut (124)
Delaware (136)
Europe (27124)
Florida (477)
Georgia (115)
Hawaii (1)
Idaho (10)
Illinois (300)
India (33)
Indiana (211)
Iowa (11)
Japan (134)
Kansas (22)
Kentucky (10)
Louisiana (10)
Maine (25)
Maryland (361)
Massachusetts (2133)
Michigan (57)
Minnesota (169)
Mississippi (3)
Missouri (39)
Montana (5)
Nebraska (4)
Nevada (38)
New Hampshire (16)
New Jersey (1124)
New Mexico (3)
New York (1012)
North Carolina (434)
Northern California (1618)
Ohio (62)
Oklahoma (2)
Oregon (4)
Pennsylvania (703)
Puerto Rico (5)
Rhode Island (10)
South America (325)
South Carolina (11)
Southern California (1216)
Tennessee (61)
Texas (512)
United States (11633)
Utah (109)
Vermont (1)
Virginia (96)
Washington D.C. (24)
Washington State (266)
West Virginia (3)
Wisconsin (21)
181,551 Results for "100".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Prothena Announces up to $100 Million Share Repurchase Plan
March 2, 2026
·
3 min read
Press Releases
Candel Therapeutics Announces Proposed $100 Million Public Offering
February 19, 2026
·
5 min read
Press Releases
Larimar Therapeutics Announces Pricing of Upsized $100 Million Underwritten Public Offering
February 26, 2026
·
4 min read
Press Releases
LB Pharmaceuticals Announces $100.0 Million Private Placement
February 5, 2026
·
5 min read
Press Releases
Marriott foundations give $100 million to Mayo Clinic for healthcare transformation
February 8, 2026
·
4 min read
Press Releases
Ecotone AI Breaks the Genomics Cost Barrier, Cutting Genome Processing from $100 to Under $1
New GPU-powered system reduces whole-genome processing time from hours to minutes, unlocking population-scale genetic discovery and accelerating rare disease drug development
February 25, 2026
·
1 min read
Press Releases
OrthoTrophix Announces Early Completion of Enrollment in Phase 2b Trial of TPX-100 in Knee Osteoarthritis
February 24, 2026
·
3 min read
Press Releases
Northwell’s Feinstein Institutes’ Kevin J. Tracey named to TIME100 2026 Health list
February 12, 2026
·
4 min read
Press Releases
Apimeds Pharmaceuticals and Lōkahi Therapeutics Announce FDA Type C Meeting Scheduled for LT‑100 (Apitox)
February 12, 2026
·
4 min read
Collaboration
Lilly Fronts $100M for CSL’s IL-6 Blocker to Bolster I&I, Cardiovascular Pipeline
CSL is advancing clazakizumab for the treatment of cardiovascular events in end-stage kidney disease and will retain rights over the asset in this indication. Lilly will explore other conditions.
February 18, 2026
·
2 min read
·
Tristan Manalac
1 of 18,156
Next
